Cargando…
Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis
INTRODUCTION: During the COVID-19 pandemic, electronic health record (EHR) data has been used to investigate disease severity and risk factors for severe COVID-19 in people with multiple sclerosis (pwMS). Methodological challenges including sampling bias, and residual confounding should be considere...
Autores principales: | Dillon, Paul, Siadimas, Athanasios, Roumpanis, Spyros, Fajardo, Otto, Fitovski, Kocho, Jessop, Nikki, Whitley, Louise, Muros-Le Rouzic, Erwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831975/ https://www.ncbi.nlm.nih.gov/pubmed/36716576 http://dx.doi.org/10.1016/j.msard.2023.104512 |
Ejemplares similares
-
COVID-19 in ocrelizumab-treated people with multiple sclerosis
por: Hughes, Richard, et al.
Publicado: (2021) -
Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel
por: Weberpals, Janick, et al.
Publicado: (2022) -
Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab
por: Pedotti, Rosetta, et al.
Publicado: (2021) -
The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry
por: Dillon, Paul, et al.
Publicado: (2023) -
Cas d’infection à la COVID-19 chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrelizumab (OCR) : actualisation des données de pharmacovigilance
por: Hughes, Richard, et al.
Publicado: (2021)